United Therapeutics (UTHR) Inventory Average (2010 - 2026)
United Therapeutics (UTHR) posted Inventory Average of $180.7 million for Q1 2026, up 0.5% sequentially from $179.8 million in Q4 2025, and up 11.78% YoY from $161.6 million in Q1 2025.
United Therapeutics (UTHR) Inventory Average (2010 - 2026) Analysis & Trends
United Therapeutics has reported Inventory Average for 17 years, with the latest figure at $180.7 million in Q1 2026.
- Quarterly Inventory Average rose 11.78% year-over-year to $180.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.7 million (up 11.78% YoY) and the FY2025 annual result came in at $170.5 million, up 26.44% from the prior year.
- Inventory Average grew to $180.7 million in Q1 2026 per UTHR's latest filing, from $179.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $180.7 million in Q1 2026 and troughed at $89.0 million in Q2 2022.
- A 5-year average of $128.5 million and a median of $116.0 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2024: Inventory Average retreated 3.05% in 2022, then soared 40.95% in 2024.
- Over 5 years, Inventory Average stood at $96.5 million in 2022, then rose by 11.97% to $108.0 million in 2023, then jumped by 40.95% to $152.3 million in 2024, then gained by 18.06% to $179.8 million in 2025, then gained by 0.5% to $180.7 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $180.7 million, $179.8 million, and $172.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 186.05 Mn |
| Mar 31, 2026 | 180.70 Mn |
| Dec 31, 2025 | 179.80 Mn |
| Sep 30, 2025 | 172.85 Mn |
| Jun 30, 2025 | 167.30 Mn |
| Mar 31, 2025 | 161.65 Mn |
| Dec 31, 2024 | 152.30 Mn |
| Sep 30, 2024 | 141.60 Mn |
| Jun 30, 2024 | 128.35 Mn |
| Mar 31, 2024 | 116.00 Mn |
| Dec 31, 2023 | 108.05 Mn |
| Sep 30, 2023 | 103.80 Mn |
| Jun 30, 2023 | 102.90 Mn |
| Mar 31, 2023 | 102.25 Mn |
| Dec 31, 2022 | 96.50 Mn |
| Sep 30, 2022 | 90.45 Mn |
| Jun 30, 2022 | 89.05 Mn |
| Mar 31, 2022 | 91.00 Mn |
| Dec 31, 2021 | 95.25 Mn |
| Sep 30, 2021 | 93.30 Mn |